MOH — authorised 23 February 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇦🇪 Farydak in United Arab Emirates
MOH authorised Farydak on 23 February 2015
Marketing authorisation
Farydak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United Arab Emirates
Frequently asked questions
Is Farydak approved in United Arab Emirates?
Yes. MOH authorised it on 23 February 2015.
Who is the marketing authorisation holder for Farydak in United Arab Emirates?
NOVARTIS PHARMS CORP holds the UAE marketing authorisation.